Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial

Jennifer T. Smilowitz; Jackelyn Moya; Melissa A. Breck; Chelsea Cook; Annette Fineberg; Kathleen Angkustsiri; Mark A. Underwood

doi:10.1186/s12887-017-0886-9

Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial

BMC Pediatrics ◽

10.1186/s12887-017-0886-9 ◽

2017 ◽

Vol 17 (1) ◽

Cited By ~ 18

Author(s):

Jennifer T. Smilowitz ◽

Jackelyn Moya ◽

Melissa A. Breck ◽

Chelsea Cook ◽

Annette Fineberg ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Bifidobacterium Longum ◽

Phase I Clinical Trial ◽

Breastfed Infants ◽

Bifidobacterium Longum Subspecies Infantis

Download Full-text

Erratum to: Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial

BMC Pediatrics ◽

10.1186/s12887-017-0932-7 ◽

2017 ◽

Vol 17 (1) ◽

Cited By ~ 1

Author(s):

Jennifer T. Smilowitz ◽

Jackelyn Moya ◽

Melissa A. Breck ◽

Chelsea Cook ◽

Annette Fineberg ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Bifidobacterium Longum ◽

Phase I Clinical Trial ◽

Breastfed Infants ◽

Bifidobacterium Longum Subspecies Infantis

Download Full-text

Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial

BMC Complementary and Alternative Medicine ◽

10.1186/s12906-016-1016-1 ◽

2015 ◽

Vol 16 (1) ◽

Cited By ~ 12

Author(s):

Yana Emmy Hoy-Schulz ◽

Kaniz Jannat ◽

Thomas Roberts ◽

Saira Husain Zaidi ◽

Leanne Unicomb ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Randomized Clinical Trial ◽

Lactobacillus Reuteri ◽

Bifidobacterium Longum ◽

Bifidobacterium Longum Subspecies Infantis

Download Full-text

Phase I Clinical Trial of a Genetically Modified and Oncolytic Vaccinia Virus GL-ONC1 in patients with peritoneal carcinomatosis

Zeitschrift für Gastroenterologie ◽

10.1055/s-0032-1324086 ◽

2012 ◽

Vol 50 (08) ◽

Author(s):

UM Lauer ◽

M Zimmermann ◽

U Koppenhöfer ◽

M Bitzer ◽

NP Malek ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Vaccinia Virus ◽

Peritoneal Carcinomatosis ◽

Genetically Modified ◽

Phase I Clinical Trial

Download Full-text

SAFETY OF A NEW CUBAN PNEUMOCOCCAL CONJUGATE VACCINE: A PHASE I CLINICAL TRIAL IN INFANTS 7 MONTH-OLD

10.26226/morressier.5731f0d7d462b8029237fd99 ◽

2016 ◽

Author(s):

Rinaldo Puga-Gomez

Keyword(s):

Clinical Trial ◽

Phase I ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Phase I Clinical Trial

Download Full-text

Faculty Opinions recommendation of Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1118816.793494158 ◽

2014 ◽

Author(s):

Thomas Flaig

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase I ◽

Abiraterone Acetate ◽

Selective Inhibitor ◽

Phase I Clinical Trial ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Faculty Opinions recommendation of A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718026292.793481389 ◽

2013 ◽

Author(s):

Steve Plaxe ◽

Kristy Ward

Keyword(s):

Ovarian Cancer ◽

Clinical Trial ◽

Phase I ◽

Recurrent Ovarian Cancer ◽

Phase I Clinical Trial ◽

Conditionally Replicative Adenovirus

Download Full-text

Faculty Opinions recommendation of GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726394953.793529283 ◽

2017 ◽

Author(s):

Lucy Dorrell

Keyword(s):

Clinical Trial ◽

Human Papillomavirus ◽

Phase I ◽

Therapeutic Vaccine ◽

Phase I Clinical Trial ◽

Cervical Cytology ◽

Human Papillomavirus 16 ◽

Normal Cervical Cytology

Download Full-text

Faculty Opinions recommendation of Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.736011651.793576740 ◽

2020 ◽

Author(s):

Roger Barker

Keyword(s):

Clinical Trial ◽

Phase I ◽

Phase I Clinical Trial

Download Full-text

Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

Annals of Oncology ◽

10.1016/j.annonc.2020.10.474 ◽

2021 ◽

Vol 32 (1) ◽

pp. 120-121

Author(s):

S. Hiltbrunner ◽

C. Britschgi ◽

P. Schuberth ◽

L. Bankel ◽

T.D.L. Nguyen-Kim ◽

...

Keyword(s):

Clinical Trial ◽

T Cells ◽

Phase I ◽

Local Delivery ◽

Fibroblast Activation Protein ◽

Phase I Clinical Trial ◽

Pleural Mesothelioma ◽

First Report ◽

Car T Cells ◽

Car T

Download Full-text

A Phase I Clinical Trial to Evaluate the Safety of HU‐045 for Treating Moderate to Severe Glabellar Lines: A Pilot Study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.17369 ◽

2021 ◽

Author(s):

HS Han ◽

JW Park ◽

KH Yoo ◽

BJ Kim

Keyword(s):

Clinical Trial ◽

Pilot Study ◽

Phase I ◽

Phase I Clinical Trial

Download Full-text